High grade intraepithelial neoplasia of prostate is associated with values of prostate specific antigen related parameters intermediate between prostate cancer and normal levels

Bosnian Journal of Basic Medical Sciences

Volumn 11, Issue 4, 2011, Pages 223-227

  Obralic, Nermina ^a   Kulovac, Benjamin ^b  

^a KLINICKI CENTAR UNIVERZITETA U SARAJEVU   (Bosnia and Herzegovina)

^b UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Prostate intraepithelial neoplasia; Prostate specific antigen

Indexed keywords

EID: 82555201627     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2011.2551     Document Type: Article

References (23)

1. Montironi R, Vela Navarrete R, Lopez-Beltran A, Mazzucchelli R, Mikuz G, Bono AV. Histopathology reporting of prostate needle biopsies. 2005 update. Virchows Arch. 2006;449(1):1-13
2. Zhou M, Magi-Galluzzi C. Genitourinary pathology: Churchill Liv-ingstone/Elsevier; 2007.
3. Bostwick DG, Meiers I. Atypical small acinar proliferation in the prostate: clinical significance in 2006. Arch Pathol Lab Med. 2006;130(7):952-7
4. Raviv G, Zlotta AR, Janssen T, Descamps F, Vanegas JP, Verhest A, et al. Do prostate specific antigen and prostate specific antigen density enhance the detection of prostate carcinoma after initial diagnosis of prostatic intraepithelial neoplasia without concurrent carcinoma? Cancer. 1996;77(10):2103-8.
5. Zlotta AR, Raviv G, Schulman CC. Clinical prognostic criteria for later diagnosis of prostate carcinoma in patients with initial isolated prostatic intraepithelial neoplasia. Eur Urol. 1996;30(2):249-55.
6. Antonelli A, Tardanico R, Giovanessi L, Pesenti N, Gatti L, Zam-bolin T, et al. Predicting prostate cancer at rebiopsies in patients with high-grade prostatic intraepithelial neoplasia: a study on 546 patients. Prostate Cancer Prostatic Dis. 2011;14(2):173-6.
7. Gallo F, Chiono L, Gastaldi E, Venturino E, Giberti C. Prognostic significance of high-grade prostatic intraepithelial neoplasia (HGPIN): risk of prostatic cancer on repeat biopsies. Urology. 2008;72(3):628-32.
8. Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol. 2005;29(9):1201-7.
9. Kronz JD, Shaikh AA, Epstein JI. High-grade prostatic intraepithe-lial neoplasia with adjacent small atypical glands on prostate biopsy. Hum Pathol. 2001;32(4):389-95.
10. Aganovic D, Prcic A, Kulovac B, Hadziosmanovic O. Prostate cancer detection rate and the importance of premalignant lesion in rebiopsy. Med Arh. 2011;65(2):109-12.
11. Auskalnis S, Milonas D, Jievaltas M, Vaiciunas K, Mickevicius A, Gudinaviciene I. The role of high-grade prostatic intraepithelial neoplasia for biochemical relapse of prostate carcinoma after radical prostatectomy. Medicina (Kaunas). 2010;46(9):604-10.
12. Morote J, Rigau M, Garcia M, Mir C, Ballesteros C, Planas J, et al. Behavior of the PCA3 gene in the urine of men with high grade prostatic intraepithelial neoplasia. World J Urol. 2010;28(6):677-80.
13. Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ. The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels. J Urol. 1999;162(5):1587-90.
14. Haggman MJ, Adolfsson J, Khoury S, Montie JE, Norlen J. Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract. Scand J Urol Nephrol Suppl. 2000(205):44-9.
15. Haggman MJ, Macoska JA, Wojno KJ, Oesterling JE. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J Urol. 1997;158(1):12-22.
16. Park S, Shinohara K, Grossfeld GD, Carroll PR. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001;165(5):1409-14.
17. Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, et al. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol. 2005;174(4 Pt 1):1256-60; discussion 60-1; author reply 61.
18. Aus G, Abbou CC, Pacik D, Schmid HP, van Poppel H, Wolff JM, et al. EAU guidelines on prostate cancer. Eur Urol. 2001;40(2):97-101.
19. Lakhey M, Ghimire R, Shrestha R, Bhatta AD. Correlation of serum free prostate-specific antigen level with histological findings in patients with prostatic disease. Kathmandu Univ Med J (KUMJ). 2010;8(30):158-63.
20. Christensson A, Bjork T, Nilsson O, Dahlen U, Matikainen MT, Cockett AT, et al. Serum prostate specific antigen complexed to alpha 1-antichymotrypsin as an indicator of prostate cancer. J Urol. 1993;150(1):100-5.
21. Tarle M, Kraljic I. Free and total serum PSA values in patients with prostatic intraepithelial neoplasia (PIN), prostate cancer and BPH. Is F/T PSA a potential probe for dormant and manifest cancer? Anticancer Res. 1997;17(3A):1531-4.
22. Filella X, Truan D, Alcover J, Quinto L, Molina R, Luque P, et al. Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms. Urology. 2004;63(6):1100-3; discussion 3-4.
23. Borboroglu PG, Sur RL, Roberts JL, Amling CL. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol. 2001;166(3):866-70.